# Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/thrombopoietin-receptor-agonists-tpo-ras-drug-class-considerations-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jeffrey A. Gilreath,Mimi Lo,Joseph Bubalo |
| Citations | 110 |
| DOI | 10.1007/s40265-021-01553-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40265-021-01553-7.pdf |
| OpenAlex ID | https://openalex.org/W3176574681 |
| PMID | 34160821 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jeffrey A. Gilreath](https://scholariq.org/researchers/jeffrey-a-gilreath/)

## Paper journal

- [Drugs](https://scholariq.org/journals/drugs/)

## Paper primary topic

- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

## Paper topics

- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.